Organigram Global (OGI) Preferred Shares (2025 - 2026)

Organigram Global (OGI) posted quarterly Preferred Shares of $39.0 million for Q1 2026, down 1.09% on a QoQ basis from $39.5 million in Q4 2025.

Organigram Global (OGI) Preferred Shares (2025 - 2026) Analysis & Trends

Organigram Global (OGI) has reported Preferred Shares for 2 consecutive years, with $39.0 million the latest figure, recorded in Q1 2026.

  • Quarterly Preferred Shares changed N/A year-over-year to $39.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $39.0 million (changed N/A YoY) and the FY2025 annual result came in at $39.5 million, changed N/A from the prior year.
  • Preferred Shares retreated to $39.0 million in Q1 2026 per OGI's latest filing, from $39.5 million in the prior quarter.
  • Over the last five years, Preferred Shares for OGI reached as high as $49.9 million in Q3 2025 and fell as low as $39.0 million in Q1 2026.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Shares (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn -
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn -
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn -
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn -
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn -
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn -
10 Organigram Global 89.89 Mn 122.96 Mn 28.97 Mn 39.02 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 39.02 Mn
Dec 31, 2025 39.45 Mn
Sep 30, 2025 49.89 Mn